Analysis of the peripheral blood t-cell receptor (tcr) repertoire in monozygotic twins discordant for crohn's disease
- 1 January 1994
- journal article
- research article
- Published by Taylor & Francis in Autoimmunity
- Vol. 17 (3) , 241-248
- https://doi.org/10.3109/08916939409010660
Abstract
T cell involvement in the inflammatory process of Crohn's Disease (CD) is evident by an increase in activated T cells and their cytokines in actively inflamed CD tissue. It has been suggested that CD may involve a superantigen based on the observation that a significant proportion of CD patients express elevated levels of VfJ8 + T cells in their peripheral blood compared to normal controls. In order to determine whether a superantigen might play a role in the pathogenesis of CD we have compared the TCR repertoires of four pairs of monozygotic twins discordant for CD. By using monozygotic twins, we could rule out the effects of HLA and other genes on the TCR repertoire. The TCR repertoires were analyzed by using a panel of V-segment-specific rnAb and by quantitative polymerase chain reaction (qPCR) using VP-specific oligonucleotide primers. In all cases the TCR repertoires of the affected and unaffected sibs were strikingly similar. We did not observe any TCR segment that was consistently altered in frequency or expression levels in all of the affected sibs compared to their identical twin. Furthermore, we did not see an increase in V(38 + T cells in the peripheral blood of the CD sibs relative to their normal counterpart. These studies suggest that the presence of CD does not alter the TCR repertoire of peripheral blood in any obvious way and argue against the role of a superantigen in the etiology or pathogenesis of CD.Keywords
This publication has 41 references indexed in Scilit:
- Cyclosporin in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2007
- Increased interleukin-2 messenger RNA in the intestinal mucosal lesions of Crohn's disease but not ulcerative colitisGastroenterology, 1992
- Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel diseaseGastroenterology, 1991
- The Role of Ciclosporin Therapy in Crohn’s DiseaseDigestive Diseases, 1991
- Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and macrophages in the intestinal lesions in Crohn's disease and ulcerative colitis.Gut, 1990
- A Placebo-Controlled, Double-Blind, Randomized Trial of Cyclosporine Therapy in Active Chronic Crohn's DiseaseNew England Journal of Medicine, 1989
- Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens.Gut, 1987
- CYCLOSPORIN FOR CROHN'S DISEASEThe Lancet, 1984
- Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques.Gut, 1984
- Treatment of Crohn's Disease with 6-MercaptopurineNew England Journal of Medicine, 1980